| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 777.60B | 753.13B | 741.39B | 764.70B | 739.26B |
| Gross Profit | 283.97B | 271.43B | 223.94B | 188.75B | 228.32B |
| EBITDA | 135.17B | 136.79B | 95.09B | 54.13B | 112.73B |
| Net Income | 79.41B | 79.34B | 43.69B | 11.71B | 64.77B |
Balance Sheet | |||||
| Total Assets | 1.18T | 1.11T | 1.06T | 1.10T | 1.01T |
| Cash, Cash Equivalents and Short-Term Investments | 257.38B | 253.28B | 196.65B | 162.72B | 71.06B |
| Total Debt | 2.38B | 30.10B | 40.32B | 203.62B | 96.46B |
| Total Liabilities | 176.64B | 174.03B | 180.60B | 323.65B | 254.97B |
| Stockholders Equity | 997.34B | 926.00B | 868.16B | 769.25B | 746.34B |
Cash Flow | |||||
| Free Cash Flow | 80.80B | 112.28B | 219.24B | 5.34B | -163.60B |
| Operating Cash Flow | 102.34B | 129.87B | 237.09B | 44.43B | -103.66B |
| Investing Cash Flow | -17.63B | -37.87B | -25.62B | -37.68B | -27.89B |
| Financing Cash Flow | -99.17B | -33.55B | -191.28B | 80.97B | 52.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥1.56T | 16.93 | ― | 2.18% | 3.25% | 1.71% | |
78 Outperform | ¥271.75B | 24.11 | ― | 1.17% | 23.18% | 15.70% | |
74 Outperform | ¥301.50B | 11.92 | 7.86% | 2.55% | 5.68% | 41.20% | |
72 Outperform | ¥79.68B | 7.91 | 6.66% | 3.36% | 5.39% | 61.68% | |
66 Neutral | ¥425.38B | 55.37 | 11.46% | 3.77% | 2.76% | 56.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥120.11B | 26.06 | 2.64% | 2.30% | 0.90% | 15.74% |